If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Progressive publishes new research

27 Jan 2022 07:40

RNS Number : 8298Z
IDOX PLC
27 January 2022
 

Progress on all fronts

 

Idox's results for the year to 31 October 2021 were released this morning. The company has delivered three things during the year: material progress on all financial metrics, a major refocus through both acquisitions and disposals, and a number of clear steps forward in terms of organisational structure and maturity. We make no material changes to FY22 or FY23 estimates, and introduce estimates for FY24.

Click here for full analysis

 

Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement. 

About Progressive:

 

Progressive helps you make informed investment decisions. FCA authorised and regulated, and with a 15-strong team of highly experienced analysts, we provide freely available institutional grade equity research and access to company management teams across every sector of the market.

 

www.progressive-research.com

 

Broad coverage

 

Analyst calibre

 

across 12 sectors

 

 

 

 

 

 

 

 

Business Services

Oil & Gas

15analysts

with average

20years

Financials

Property

experience of

Healthcare

Retail

 

Industrials

Technology

30+

 

techMARK

Investment Trusts

Telecoms

industry based

Extel

Mining

Utilities

awards

StarMine

 

 

For further information please contact:

 

Keith Hodgskiss

+44 (0) 20 7781 5300

khodgskiss@progressive-research.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABKOBNOBKKFDB
Date   Source Headline
21st Feb 20227:00 amRNSDirectorate Change
11th Feb 20228:46 amRNSGrant of Options
27th Jan 20227:40 amRNSProgressive publishes new research
27th Jan 20227:00 amRNSFinal Results
12th Jan 20227:00 amRNSNotice of Final Results
9th Dec 20219:50 amRNSIdox hosts company event focused on sustainability
25th Nov 20217:00 amRNSExercise of Share Options & Total Voting Rights
16th Nov 20217:00 amRNSYear End Trading Update
7th Oct 20218:08 amRNSHolding(s) in Company
5th Oct 20217:00 amRNSAcquisition
1st Oct 202111:25 amRNSExercise of Share Options & Total Voting Rights
9th Aug 20217:00 amRNSAcquisition
23rd Jul 20212:01 pmRNSHolding(s) in Company
19th Jul 20211:47 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSExercise of Share Options & Total Voting Rights
15th Jun 20217:00 amRNSHalf-year Report
7th Jun 20217:00 amRNSAcquisition
2nd Jun 20217:00 amRNSExercise of Share Options & Total Voting Rights
24th May 202111:40 amRNSInvestor presentation
20th May 20217:00 amRNSFY21 H1 Trading Update
23rd Apr 20214:00 pmRNSExercise of Share Options & Total Voting Rights
15th Apr 20211:41 pmRNSGrant of Options
13th Apr 20217:00 amRNSExercise of Share Options & Total Voting Rights
12th Apr 20219:40 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSFY21 Q1 Trading Update
22nd Mar 20212:46 pmRNSForm 8.3 - IDOX PLC
19th Mar 20219:07 amRNSForm 8.5 (EPT/RI) IDOX Plc
19th Mar 20217:01 amRNSDisposal of Idox Grants Consultancy business
19th Mar 20217:00 amRNSStatement regarding Dye & Durham’s withdrawal
18th Mar 20211:11 pmRNSResult of AGM
18th Mar 20218:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
17th Mar 202110:51 amGNWForm 8.3 - IDOX PLC
17th Mar 20217:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
16th Mar 20211:08 pmRNSForm 8.3 Disclosure
16th Mar 202112:00 pmRNSForm 8.5 (EPT/RI) IDOX Plc
16th Mar 20219:54 amGNWForm 8.3 - Idox plc
15th Mar 20218:27 amRNSForm 8.5 (EPT/RI) IDOX Plc
15th Mar 20217:00 amRNSTotal Voting Ritghts & Rule 2.9 Announcement
12th Mar 202112:03 pmGNWForm 8.3 - [IDOX plc - 11-03-2021] - (CGWL)
12th Mar 20218:57 amRNSForm 8.5 (EPT/RI) IDOX Plc
12th Mar 20217:00 amRNSDisposal of Idox Compliance
11th Mar 20212:17 pmRNSForm 8.3 Disclosure
11th Mar 202111:38 amGNWForm 8.3 - [IDOX plc - 10-03-2021] - (CGWL)
11th Mar 20218:21 amRNSForm 8.5 (EPT/RI) IDOX Plc
10th Mar 202111:54 amGNWForm 8.3 - [IDOX plc - 09-03-2021] - (CGWL)
10th Mar 20219:46 amRNSForm 8.5 (EPT/RI)
10th Mar 20219:22 amRNSForm 8.5 (EPT/RI) IDOX Plc
9th Mar 202111:44 amGNWForm 8.3 - [IDOX plc - 08-03-2021] - (CGWL)
9th Mar 20218:44 amRNSForm 8.5 (EPT/RI) IDOX Plc
8th Mar 20214:34 pmRNSForm 8.3 - IDOX PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.